Sionna Therapeutics, Inc.
SION
$39.01
$0.050.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.98% | 8.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.67% | 11.43% | |||
| Operating Income | -8.67% | -11.43% | |||
| Income Before Tax | -12.23% | -9.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.23% | -9.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.23% | -9.62% | |||
| EBIT | -8.67% | -11.43% | |||
| EBITDA | -8.53% | -11.58% | |||
| EPS Basic | -11.89% | 33.92% | |||
| Normalized Basic EPS | -11.88% | 33.90% | |||
| EPS Diluted | -11.89% | 33.92% | |||
| Normalized Diluted EPS | -11.88% | 33.90% | |||
| Average Basic Shares Outstanding | 0.31% | 65.88% | |||
| Average Diluted Shares Outstanding | 0.31% | 65.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||